CLINICAL_TRIALS
withdrawal
· 2019-11-21
Clinical Trial Update: Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction [Phase 2, Phase 3]
Summary
A clinical trial evaluating testosterone replacement to improve exercise capacity in hypogonadal men after acute myocardial infarction has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Texas Tech University Health Sciences Center | Conditions: Hypogonadism, Acute Myocardial Infarction: Rehabilitation Phase | Phase 2, Phase 3 | Status: WITHDRAWN